Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Biochemical Journal

• Publication date

  1995-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1042/BJ3080645PMID 7772054PMCID PMC1136975
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A matrix metalloproteinase expressed on the surface of invasive tumour cells

  1994cited by this paper
• Activity of ternary gelatinase A-TIMP-2-matrix metallo-proteinase complexes.

  1994cited by this paper
• Human progelatinase A can be activated by matrilysin

  1994cited by this paper
• Metalloproteinase domain structure, cellular invasion and metastasis.

  1994cited by this paper
• Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2.

  1993cited by this paper
• Expression of human recombinant 72 kDa gelatinase and tissue inhibitor of metalloproteinase-2 (TIMP-2): characterization of complex and free enzyme.

  1993cited by this paper
• Matrix metalloproteinases: a review.

  1993cited by this paper
• The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: a kinetic analysis of the inhibition of gelatinase A.

  1993cited by this paper
• Tumor cell interactions with the extracellular matrix during invasion and metastasis.

  1993cited by this paper
• Matrix metalloproteinases cleave at two distinct sites on human cartilage link protein.

  1993cited by this paper
• Disruption of the cysteine-75 and zinc ion coordination is not sufficient to activate the precursor of human matrix metalloproteinase 3 (stromelysin 1).

  1993cited by this paper
• The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases.

  1992cited by this paper
• Domain structure of human 72-kDa gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions.

  1992cited by this paper
• Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9.

  1992cited by this paper
• Higher-order complex formation between the 72-kilodalton type IV collagenase and tissue inhibitor of metalloproteinases-2.

  1992cited by this paper
• The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B.

  1992cited by this paper
• Activation of TIMP-2/progelatinase A complex by stromelysin.

  1992cited by this paper
• Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells.

  1992cited by this paper
• Differential roles for two gelatinolytic enzymes of the matrix metalloproteinase family in the remodelling cornea.

  1991cited by this paper
• Matrix metalloproteinases and their inhibitors in connective tissue remodeling

  1991cited by this paper
• The complex between a tissue inhibitor of metalloproteinases (TIMP-2) and 72-kDa progelatinase is a metalloproteinase inhibitor.

  1991cited by this paper
• Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes.

  1991cited by this paper
• Binding of tissue inhibitor of metalloproteinases 2 to two distinct sites on human 72-kDa gelatinase. Identification of a stabilization site.

  1991cited by this paper
• Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinases-2.

  1991cited by this paper
• Purification of recombinant human prostromelysin. Studies on heat activation to give high-Mr and low-Mr active forms, and a comparison of recombinant with natural stromelysin activities.

  1991cited by this paper
• Autoradiography using storage phosphor technology

  1990cited by this paper
• Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines.

  1990cited by this paper
• Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties.

  1990cited by this paper
• Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. Induction and endogenous activation of collagenase, 72-kDa gelatinase, and Pump-1 is accompanied by the suppression of the tissue inhibitor of matrix metalloproteinases.

  1990cited by this paper
• Morphology and anatomic localization of renal microneoplasms and proximal tubule dysplasias induced by four different estrogens in the hamster.

  1990cited by this paper
• Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation.

  1990cited by this paper
• The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family.

  1990cited by this paper
• Interaction of human rheumatoid synovial collagenase (matrix metalloproteinase 1) and stromelysin (matrix metalloproteinase 3) with human alpha 2-macroglobulin and chicken ovostatin. Binding kinetics and identification of matrix metalloproteinase cleavage sites.

  1989cited by this paper
• The activation of human type IV collagenase proenzyme. Sequence identification of the major conversion product following organomercurial activation.

  1989cited by this paper
• Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family.

  1989cited by this paper
• Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2.

  1989cited by this paper
• Evidence that human rheumatoid synovial matrix metalloproteinase 3 is an endogenous activator of procollagenase.

  1988cited by this paper
• H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen.

  1988cited by this paper
• Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes.

  1987cited by this paper
• A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization.

  1986cited by this paper
• Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase.

  1985cited by this paper
• Alpha 2-macroglobulin.

  1981cited by this paper
• The interaction of alpha 2-macroglobulin with proteinases. Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism.

  1973cited by this paper
• An endopeptidase from rheumatoid synovial tissue culture.

  1972cited by this paper

• Methods to Assess the Impact of Hsp90 Chaperone Function on Extracellular Client MMP2 Activity.

  2023cites this paper
• Cyclooxygenase Inhibition Alters Proliferative, Migratory, and Invasive Properties of Human Glioblastoma Cells In Vitro

  2021cites this paper
• The Influence of Differentially Expressed Tissue-Type Plasminogen Activator in Experimental Autoimmune Encephalomyelitis: Implications for Multiple Sclerosis

  2016cites this paper
• Nuclear matrix metalloproteinase-2 and investigation of its potential targets in myocardial ischemia-reperfusion injury

  2016cites this paper
• KLK6 proteolysis is implicated in the turnover and uptake of extracellular alpha-synuclein species

  2016cites this paper
• Collagenolytic Matrix Metalloproteinase Activities toward Peptomeric Triple-Helical Substrates.

  2015cites this paper
• Matrix-Assisted Refolding, Purification and Activity Assessment Using a ‘Form Invariant’ Assay for Matrix Metalloproteinase 2 (MMP2)

  2014cites this paper
• Moving towards personalised therapy in patients with hepatocellular carcinoma: the role of the microenvironment

  2014cites this paper
• Hepatocyte Produced Matrix Metalloproteinases Are Regulated by CD147 in Liver Fibrogenesis

  2014cites this paper
• Membrane type-1 matrix metalloproteinase (MT1-MMP) as a target in cancer therapy.

  2014cites this paper
• Analysis Of The Structure And Function Of A Timp-1/cd63 Complex And Its Relationship To An Mt1-Mmp/cd63 Complex

  2013cites this paper
• Functional proteomic analysis of seminal plasma proteins in men with various semen parameters

  2013cites this paper
• Detection of a latent soluble form of membrane type 1 matrix metalloprotease bound with tissue inhibitor of matrix metalloproteinases‐2 in periprosthetic tissues and fluids from loose arthroplasty endoprostheses

  2013cites this paper
• Matrix Metallopeptidase-2/Gelatinase A

  2013cites this paper
• Aqueous zymography screening of matrix metalloproteinase activity and inhibition based on colorimetric gold nanoparticles.

  2012cites this paper
• Expression of soluble and functional full-length human matrix metalloproteinase-2 in Escherichia coli.

  2012cites this paper
• Active MMP-2 Activity Discriminates Colonic Mucosa, Adenomas with and without High Grade Dysplasia and Cancers

  2011cites this paper
• Active matrix metalloproteinase-2 activity discriminates colonic mucosa, adenomas with and without high-grade dysplasia, and cancers.

  2011cites this paper
• Exosite Interactions Impact Matrix Metalloproteinase Collagen Specificities*

  2011cites this paper
• Purification of MMPs and TIMPs.

  2010cites this paper
• Optimization of total protein and activity assays for the detection of MMP-12 in induced human sputum

  2010influential citation
• The C-terminal domains of ADAMTS-4 and ADAMTS-5 promote association with N-TIMP-3.

  2009cites this paper
• Active MMP‐2 effectively identifies the presence of colorectal cancer

  2009cites this paper
• Effect of Methamphetamine on Gingival Fibroblast Production of Matrix Metalloproteinase (MMP)-2 and -9 and Tissue Inhibitor of Metalloproteinase (TIMP)-1 and -2 In Vitro

  2009cites this paper
• Stromal expression of MMP-13 is required for melanoma invasion and metastasis.

  2009cites this paper
• High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.

  2009cites this paper
• Catalytic properties of ADAM12 and its domain deletion mutants.

  2008cites this paper
• Selective Modulation of Matrix Metalloproteinase 9 (MMP-9) Functions via Exosite Inhibition*

  2008cites this paper
• Triple-helical transition state analogues: a new class of selective matrix metalloproteinase inhibitors.

  2007cites this paper
• Inhibition of matrix metalloproteinase activity by ACE inhibitors prevents left ventricular remodeling in a rat model of heart failure.

  2007cites this paper
• Proteolytic profiling of the extracellular matrix degradome.

  2007cites this paper
• Engineered Sarafotoxins as Tissue Inhibitor of Metalloproteinases-like Matrix Metalloproteinase Inhibitors*

  2007cites this paper
• Proteolytic Activities of Human ADAMTS-5

  2007cites this paper
• Differentiation of secreted and membrane-type matrix metalloproteinase activities based on substitutions and interruptions of triple-helical sequences.

  2007cites this paper
• Expression of matrix metalloproteinases in the subretinal fluid correlates with the extent of rhegmatogenous retinal detachment

  2007cites this paper
• Mast cell-dependent activation of pro matrix metalloprotease 2: a role for serglycin proteoglycan-dependent mast cell proteases

  2006cites this paper
• Cells on Membrane Vesicles Shed by 8701-BC Breast Carcinoma Integrins , and Human Lymphocyte Antigen Class I Molecules 1 β Selective Localization of Matrix Metalloproteinase 9 , Updated

  2006cites this paper
• The Roles of Substrate Thermal Stability and P2 and P1′ Subsite Identity on Matrix Metalloproteinase Triple-helical Peptidase Activity and Collagen Specificity*

  2006cites this paper
• A Key Role for Mast Cell Chymase in the Activation of Pro-matrix Metalloprotease-9 and Pro-matrix Metalloprotease-2*

  2005cites this paper
• Effect of flavones on rat brain and lung matrix metalloproteinase activity measured by film in‐situ zymography

  2005cites this paper
• Invasiveness of breast cancer cells MDA‐MB‐231 through extracellular matrix is increased by the estradiol metabolite 4‐hydroxyestradiol

  2005cites this paper
• Matrix metalloproteinases of epithelial origin in facial sebum of patients with acne and their regulation by isotretinoin.

  2005cites this paper
• Roles of Immune-Cell-Derived Matrix Metalloproteinases in Tumor Growth and Metastasis

  2005cites this paper
• Extracellular Processing of MHC Class I Antigens

  2004cites this paper
• Low Density Lipoprotein Receptor-related Protein Mediates Endocytic Clearance of Pro-MMP-2·TIMP-2 Complex through a Thrombospondin-independent Mechanism*

  2004cites this paper
• 129 – Gelatinase A

  2004cites this paper
• Proteolytic imbalance is reversed after therapeutic surgery in breast cancer patients

  2004cites this paper
• Expression of matrix metalloproteinases and their endogenous tissue inhibitors in skin lesions from patients with tuberous sclerosis.

  2004cites this paper
• MMP-2, MMP-9, TIMP-1 and TIMP-2 levels in patients with rheumatoid arthritis and psoriatic arthritis.

  2004cites this paper
• Biological and clinical relevance of Laminin-5 in cancer

  2004cites this paper
• Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases: Structure, Function, and Biochemistry

  2003cites this paper
• Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Structure , Function , and Biochemistry

  2003cites this paper
• Differential activation of matrix metalloproteinases in heart failure with and without ventricular dilatation.

  2003cites this paper
• Expression and activity of matrix metalloproteinase 2 and 9 in human trophoblasts.

  2003cites this paper
• Zymography of Metalloproteinases

  2003cites this paper
• Tissue remodelling in liver diseases.

  2003cites this paper
• Analysis of matrix metalloproteinase triple-helical peptidase activity with substrates incorporating fluorogenic L- or D-amino acids.

  2003cites this paper
• Activation of matrix metalloproteinase-2 and -9 by 2- and 4-hydroxyestradiol.

  2003cites this paper
• Regulation of MMPs and TIMPs by IL-1beta during corneal ulceration and infection.

  2003cites this paper
• Selective Hydrolysis of Triple-helical Substrates by Matrix Metalloproteinase-2 and -9*

  2003cites this paper
• Differential activation of matrix metalloproteinases in heart failure with and without ventricular dilatation

  2003cites this paper
• Gelatinolytic activities in muscle of Atlantic cod (Gadus morhua), spotted wolffish (Anarhichas minor) and Atlantic salmon (Salmo salar)

  2003cites this paper
• Nitric oxide inhibition increases aortic wall matrix metalloproteinase-9 expression.

  2002cites this paper
• E. coli expression of TIMP-4 and comparative kinetic studies with TIMP-1 and TIMP-2: insights into the interactions of TIMPs and matrix metalloproteinase 2 (gelatinase A).

  2002cites this paper
• Gelatinases and their inhibitors in tumor metastasis: from biological research to medical applications.

  2002cites this paper
• Activation of Progelatinase A by Mammalian Legumain, a Recently Discovered Cysteine Proteinase

  2001cites this paper
• Activation of progelatinase A (MMP‐2) by neutrophil elastase, cathepsin G, and proteinase‐3: A role for inflammatory cells in tumor invasion and angiogenesis

  2001cites this paper
• Human hepatocellular carcinoma (HCC) cells require both alpha3beta1 integrin and matrix metalloproteinases activity for migration and invasion.

  2001cites this paper
• Homophilic complex formation of MT1‐MMP facilitates proMMP‐2 activation on the cell surface and promotes tumor cell invasion

  2001cites this paper
• Losartan Inhibits the Angiotensin II–Induced Modifications on Fibrinolysis and Matrix Deposition by Primary Human Vascular Smooth Muscle Cells

  2001influential citation
• Human Hepatocellular Carcinoma (HCC) Cells Require Both α3β1 Integrin and Matrix Metalloproteinases Activity for Migration and Invasion

  2001cites this paper
• TIMP-3 Is a Potent Inhibitor of Aggrecanase 1 (ADAM-TS4) and Aggrecanase 2 (ADAM-TS5)*

  2001cites this paper
• Activation of Progelatinase A by Mammalian Legumain, a Recently Discovered Cysteine Proteinase

  2001cites this paper
• Gelatinolytic and collagenolytic activity in periprosthetic tissues from loose hip endoprostheses.

  2001cites this paper
• Kinetic analysis of matrix metalloproteinase activity using fluorogenic triple-helical substrates.

  2001cites this paper
• Bovine Follicular Fluid and Serum Share a Unique Isoform of Matrix Metalloproteinase-2 That Is Degraded by the Oviductal Fluid1

  2001cites this paper
• Characterization of matrix metalloproteinase in flatfish embryo undergoing formation of lenses.

  2000cites this paper
• TIMP-2 Is Required for Efficient Activation of proMMP-2 in Vivo *

  2000cites this paper
• Hydrolysis of Triple-helical Collagen Peptide Models by Matrix Metalloproteinases*

  2000cites this paper
• The Isolation, Characterization, and Molecular Cloning of a 75-kDa Gelatinase B-like Enzyme, a Member of the Matrix Metalloproteinase (MMP) Family

  2000cites this paper
• Metalloproteinases and tumor necrosis factor-alpha activities in synovial fluids of horses: correlation with articular cartilage alterations.

  2000cites this paper
• Recognition and catabolism of synthetic heterotrimeric collagen peptides by matrix metalloproteinases.

  2000cites this paper
• Matrix metalloproteinase secretion is stimulated by TGF-beta in cultured lens epithelial cells.

  1999cites this paper
• Expression and activation of matrix metalloproteinases in wounds: modulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+.

  1999cites this paper
• Engineering of Selective TIMPs

  1999cites this paper
• Modulation of gelatinase activity correlates with the dedifferentiation profile of regenerating salamander limbs.

  1999cites this paper
• Expression of matrix metalloprotease-2-cleaved laminin-5 in breast remodeling stimulated by sex steroids.

  1999cites this paper
• Stimulation of angiogenesis through cathepsin B inactivation of the tissue inhibitors of matrix metalloproteinases

  1999cites this paper
• Enhancement of membrane-type 1-matrix metalloproteinase (MT1-MMP) production and sequential activation of progelatinase A on human squamous carcinoma cells co-cultured with human dermal fibroblasts

  1999cites this paper
• Membrane associated matrix metalloproteinases in metastasis.

  1999cites this paper
• Stromelysins 1 and 2

  1998cites this paper
• Expression of Human Pro-Matrix Metalloproteinase 3 that Lacks the N-terminal 34 Residues in Escherichia coli: Autoactivation and Interaction with Tissue Inhibitor of Metalloproteinase 1 (TIMP-1)

  1998cites this paper
• Plasma Membrane-bound Tissue Inhibitor of Metalloproteinases (TIMP)-2 Specifically Inhibits Matrix Metalloproteinase 2 (Gelatinase A) Activated on the Cell Surface*

  1998cites this paper
• 72-kDa Gelatinase (Gelatinase A): Structure, Activation, Regulation, and Substrate Specificity

  1998cites this paper
• Selective localization of matrix metalloproteinase 9, beta1 integrins, and human lymphocyte antigen class I molecules on membrane vesicles shed by 8701-BC breast carcinoma cells.

  1998cites this paper
• Expression of gelatinases A and B, and TIMPs 1 and 2 during corneal wound healing.

  1998cites this paper
• Comparative analysis of the noncollagenous NC1 domain of type IV collagen: Identification of structural features important for assembly, function, and pathogenesis

  1998cites this paper
• Isolation and identification of canine matrix metalloproteinase-2 (MMP-2).

  1998cites this paper
• Intact Vitronectin Induces Matrix Metalloproteinase-2 and Tissue Inhibitor of Metalloproteinases-2 Expression and Enhanced Cellular Invasion by Melanoma Cells*

  1998cites this paper
• Activation of Type IV Procollagenases by Human Tumor-associated Trypsin-2*

  1997cites this paper